Gilead Sciences, Inc. today announced the presentation of new research data from its innovative HIV treatment portfolio and pipeline, including a broad range of data on investigational and marketed ...
It’s almost time to head back into Gilead for one last battle ... Serena to become besties just because Serena’s now gotten a ...
The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...
Elanco Animal Health Incorporated today announced the appointment of Dr. Stacey Ma to its Board of Directors, effective immediately. Dr. Ma brings extensive global leadership experience in ...
The revenues reported reflect the recognition of a portion of the upfront and milestone payments from the license agreement with Gilead. R&D expenses for the ... Assistant Professor of Medicine, ...
Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...